Preprint Adoption in the Life Sciences: A Perspective on What Changed and What Did Not

Abstract

Preprint Adoption in the Life Sciences has moved quickly from a niche research question to something a wider community can
now investigate with reasonably reliable tools, but the evidence behind it has not always kept pace. We pull together the current
evidence for preprint adoption in the life sciences, covering the methodological, practical, regulatory and cost angles, with an eye
on where practice has genuinely settled and where researchers and reviewers are still largely working it out for themselves.
Selective, context-specific adoption looks better supported by the evidence gathered here than either broad rollout or blanket
avoidance.